Nafamostat mesilate for prevention of Post-ERCP pancreatitis

被引：0
|
作者：
Yoo, Kyo-Sang
Moon, Joon Ho
Park, Kwang Hyuk
Chung, Yong Woo
Kim, Kyoung Oh
Park, Cheol Hee
Hahn, Taeho
Park, Sang Hoon
Kim, Jong Hyeok
Lee, Jin
Park, Choong Kee
机构：
来源：
GASTROINTESTINAL ENDOSCOPY | 2007年 / 65卷 / 05期
关键词：
D O I：
10.1016/j.gie.2007.03.434
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
下载
收藏
页码：AB212 / AB212
页数：1
相关论文
共 50 条
  • [1] Nafamostat mesilate for prevention of post-ERCP pancreatitis
    Ybo, Kyo-Sang
    Choi, Won Sub
    Chung, Woo
    Kim, Kyourig On
    Park, Cheol Hee
    Hahn, Taeho
    Park, Sang Hoon
    Kim, Jong Hyeok
    Lee, Jin
    Park, Choong Kee
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB153 - AB153
  • [2] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [3] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Joo Seong Kim
    Sang Hyub Lee
    Namyoung Park
    Gunn Huh
    Jung Won Chun
    Jin Ho Choi
    In Rae Cho
    Woo Hyun Paik
    Ji Kon Ryu
    Yong-Tae Kim
    BMC Gastroenterology, 22
  • [4] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, J. S.
    Lee, S. H.
    Park, N.
    Huh, G.
    Chun, J. W.
    Choi, J. H.
    Cho, I. R.
    Paik, W. H.
    Ryu, J. K.
    Kim, Y. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 134 - 134
  • [5] The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
    Kim, Joo Seong
    Lee, Sang Hyub
    Park, Namyoung
    Huh, Gunn
    Chun, Jung Won
    Choi, Jin Ho
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [6] THE EFFECT OF NAFAMOSTAT MESILATE INFUSION INTO MAIN PANCREATIC DUCT ON THE PREVENTION OF POST-ERCP PANCREATITIS
    Park, Jin-Seok
    Jeong, Seok
    Lee, Don Haeng
    GASTROENTEROLOGY, 2018, 154 (06) : S947 - S947
  • [7] Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang Ha
    Eum, Jae Sup
    Lee, Sun Mi
    Song, Geun Am
    Kim, Dong Uk
    Kim, Il Doo
    Cho, Mong
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) : E11 - E18
  • [8] Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis A Meta-analysis of Prospective, Randomized, Controlled Trials
    Yu, Ge
    Li, Shuang
    Wan, Rong
    Wang, Xingpeng
    Hu, Guoyong
    PANCREAS, 2015, 44 (04) : 561 - 569
  • [9] Urinastatin versus Nafamostat Mesylate in the prevention of post-ERCP pancreatitis
    Lee, Jungwook
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 70 - 70
  • [10] Use of nafamostat mesilate and gabexate mesylate in the prevention of post-ERCP pancreatitis and risk factor analysis: A prospective, randomized trial
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang-Ha
    Song, Geun-Am
    Eum, Jae-Sup
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB244 - AB245
12345